LAKE STREET ADVISORS GROUP, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LAKE STREET ADVISORS GROUP, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,000
+106283.0%
51,000
+8.5%
0.00%0.0%
Q2 2023$470.0%47,0000.0%0.00%0.0%
Q1 2023$47
-6.0%
47,0000.0%0.00%0.0%
Q4 2022$50
-99.9%
47,0000.0%0.00%0.0%
Q3 2022$47,000
+161.1%
47,000
+176.5%
0.00%
+200.0%
Q2 2022$18,000
-5.3%
17,0000.0%0.00%0.0%
Q1 2022$19,000
+72.7%
17,000
+70.0%
0.00%0.0%
Q4 2021$11,000
-8.3%
10,0000.0%0.00%0.0%
Q3 2021$12,00010,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 30,477,080$31,017,7581.54%
SHENKMAN CAPITAL MANAGEMENT INC 17,691,000$17,931,7261.34%
BRAIDWELL LP 37,509,000$37,250,1881.18%
III Capital Management 16,200,000$16,068,4830.81%
DLD Asset Management, LP 7,500,000$7,471,8750.80%
TENOR CAPITAL MANAGEMENT Co., L.P. 34,375,000$34,057,6740.73%
Worth Venture Partners, LLC 1,034,000$1,029,4760.61%
CAPSTONE INVESTMENT ADVISORS, LLC 40,200,000$39,922,6200.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,055,000$3,041,6340.07%
Leucadia National 7,149,000$7,051,5720.06%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders